{"name":"KBP Biosciences","slug":"kbp-biosciences","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxOazVNRzNBTnRMalIweWxsTVhDQWtLeldsQ09yb09sdXlVSUZMUGxfdkZSaDJNYkdHbWR5V0t2cm5HdjI2M2RLbzZUVGRlb0EtNlhsMzlxVC1BcFFSeDRqenZ0NHR6R0Exa18tdTAxMGRSZFdhNXd1R2ZlVnlBS2lSLW53?oc=5","date":"2025-12-19","type":"pipeline","source":"Fierce Biotech","summary":"Fierce Biotech's top editor's picks for 2025 - Fierce Biotech","headline":"Fierce Biotech's top editor's picks for 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxNVjQyTG9TTHJpX1RoanVvX2s5UDVUTnJ5RThWc19BMEg5OElmVjdFZ0kwVl9VYWw0ZHA4dlJpTFBUejk4RnM2SllzelJsb0RiTWpXYlY1VTAzMU5EVXB4Z3ltbUU0WnBFRHg0VkJQWTI1SGNjT3ZBdDFEejgzaUxkSVZpQ2t1SnBGSW4yS0NuTGR0ell6X3hzS0ZWVVktc25PNnNhSnlxdXRLRmVrT3dkQndrSC1TSUxramxOUkdkVi1mTmEz?oc=5","date":"2025-10-17","type":"deal","source":"Fierce Pharma","summary":"Fierce Pharma Asia—High-dollar licensing deals; Takeda's AI drug design pact; and the finale of Novo vs. KBP - Fierce Pharma","headline":"Fierce Pharma Asia—High-dollar licensing deals; Takeda's AI drug design pact; and the finale of Novo vs. KBP","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxQeUZEUGhSb0daR1FMTnNQbnhaX2M4V0RxUi1IZUlDZUJPMGpRbVVSekxlMnNxNUNYYmpWd1F3MUFaU2ljRlBwbVRyN01JeDB3Nk9KcEI2SlpyWkt1OTRaTDlxT0Q5andDVmM3bkg4UlZkTWJhTWdLRzhQeFNNbUV2aEh4TE1FdGpRc0N6MkJRMWZ1bWVPbTNyRnFyX1pNbEFxS2c?oc=5","date":"2025-10-02","type":"deal","source":"Fierce Biotech","summary":"Novo vs. KBP: How a $1.3B deal turned into a fraud accusation and an international legal fight - Fierce Biotech","headline":"Novo vs. KBP: How a $1.3B deal turned into a fraud accusation and an international legal fight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxQcWJFTmFDcVpIcHdrVFFhSDdsSnI2aVdXelpzTm9zQVFPS09LODNBSHVSSWtFMVRZQWN0allfSTZrbjdtSEYwNVQ2WDFUSHJLX0hzREY5UUtWZWNFQVFqek5oNVhObGFiSnNDR19wOTE5bUotRi1WcTJWNXR0TllwX2ZJVEFuY1cwNmxHSHFuM0FVU09kcVgwOGRxdEdDcVNQSWJxYzVZdjk0OVVDVlZxRHBDV1JHemFG?oc=5","date":"2025-10-02","type":"pipeline","source":"Fierce Pharma","summary":"Fierce Pharma Asia—Novo, KBP's legal brawl; Takeda's cell therapy retreat; Another Enhertu early cancer win - Fierce Pharma","headline":"Fierce Pharma Asia—Novo, KBP's legal brawl; Takeda's cell therapy retreat; Another Enhertu early cancer win","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5gFBVV95cUxNTlRMQ3Nwb0JkQmlDcVJmTlB5VGx4alJrcFZoR05QTkhxY1p2Q1JhajdTTmtsYXd0WWZWeTZjd2JTYWhEaUFIMGtLZUdhcjVkSEFfb09OOERpNGRGcFd0YW1CbU1sQkhjUGNFaHRuNzhEMkJKaDNwTWI1N0hiSHdXYXU5SUVvLVRXZkxLdTJUU2FOUGVKcGJ1cXQ3a2F3MFhjZDhfWU5LWmlBeklKY0FyUHpueWdHcmZpbzE1NU1MRkxBRnZFbFEwMVc4MVNqdkZZSk5oeWg0MFU0NWRvWTgyZG1rU0g2Zw?oc=5","date":"2025-08-13","type":"pipeline","source":"BioPharma APAC","summary":"KBP Biosciences Welcomes Court’s Decision to Maintain Injunction Pending Arbitration with Novo Nordisk - BioPharma APAC","headline":"KBP Biosciences Welcomes Court’s Decision to Maintain Injunction Pending Arbitration with Novo Nordisk","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxNanZTblJNV3BGU0FLcjdlaHRPenducmdRaVpsZkl1cnFoWjZpYy1HcXo2SU43Sng3SDVqdjVMaDUxV2RkS09BVTVrTzdoakxHWTlSek14T3RqMnZuVk0wZFJFUGFKNm5BMnVVMDRnN1B5RG5RRGdqWEZYNFlrc0Z0dzJvNHRNVFY2c2l1VHZMQzB1Q09DZHIwd1VHVXVoYkxqak96VV93?oc=5","date":"2025-08-13","type":"pipeline","source":"Scandasia","summary":"Singapore court upholds 730 million USD freezing order in favour of Novo Nordisk - Scandasia","headline":"Singapore court upholds 730 million USD freezing order in favour of Novo Nordisk","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxOUkg0WTZkRG1WdkVId2F6MUF1VXA5RHBWamE0Z3M2NXlQeXFmQlFaTjNaZHNrSHAwVFZmR2FqS3E4VHBBckxtM2JWakdQNTl1WGxCb2tCNE1fWGRuSVlTYUpVT0lEUTlnR3l0R3d2LTlYYzhaZVB2TEhOQ2ltRkp2bXZjemVDcFk?oc=5","date":"2025-02-19","type":"deal","source":"pharmaphorum","summary":"When licensing deals go bad - Novo sues KBP Bio for $830m - pharmaphorum","headline":"When licensing deals go bad - Novo sues KBP Bio for $830m","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3wFBVV95cUxPMTRLSDZSNjF5OElTQnJvVzNpdzN5YzNMdy1pLUszcHBYTmtyUDg0djFuOW1SNUdkTndFSHdsdTdCQjc4MTBWZ1k2bWxuU0pDUXBUZzdrSllWRTh5QnpqX0d0WmpDRWhsWXZnQ3d6dVhHWm9fR3Y2ZlkyQ3dKQlNoU19NSktYWlpvRnQ4Y3hmaGd1ZF8wOFl2NV9OOWVvcWQzSGNaWUpNcjJ6WHFpMXU5aUVOZkZaNGtRNTdXRXRPQ3k2b3ZYRUhJTXIxYW9TNTdVYjNaY2Z2eEhOVlBRR3J3?oc=5","date":"2025-02-18","type":"deal","source":"Reuters","summary":"Novo Nordisk alleges fraud after $1.3 billion deal to buy hypertension drug from KBP Biosciences - Reuters","headline":"Novo Nordisk alleges fraud after $1.3 billion deal to buy hypertension drug from KBP Biosciences","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE9FRE5QdjExRXVUcUw5UHcxUUVWQzNPMjZTbWQwZFR4WmVid1FLTzU3NWNjcGJsblpvYVRrSjNPcEstQ2FBbGVJRWJKYUhtU2xOVEFz?oc=5","date":"2025-02-18","type":"pipeline","source":"FirstWord Pharma","summary":"Novo seeks $830M from KBP in ocedurenone fraud case - FirstWord Pharma","headline":"Novo seeks $830M from KBP in ocedurenone fraud case","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxPcFI4b1JGaDlkQ2ZyemY3WTY4clAtUjU2Zmlpb25nZlB6R3VYUnBjUFBtWkgzdTlvNklXSWRsdTVQT0pDVjZqallXekIxQWVvTVFPa0loZWUtVnVjLXZsZVBSajZLSG42QUV1Z3JVY3hoQXREVFVIeXZmeWVOaWc4N0JOWlpJdS13SEgxLVRoSEkzNXRncXB2SURUTG94Q2h6RExSSm1ad2c?oc=5","date":"2025-02-18","type":"pipeline","source":"BioSpace","summary":"Novo Seeks $830M in Fraud Case Against Singaporean Biotech Over Kidney Drug - BioSpace","headline":"Novo Seeks $830M in Fraud Case Against Singaporean Biotech Over Kidney Drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxQSWRDNllBR1Mza1IycG5WTWU3Mi1wMDd4SHVNbE9EaHNtMWtoenZJVFZfWFVzTUtBMkpBejljRUZXd3cwb0NrVHVIemgwRjJ2S0s3b2NDQVBjY3JQQXhuZ3VXc21ETEJRZ2J2SjhzLTVEeEg4ZWhfell3RkdDanhzclBFajlFYXFEYl9HdmR5LWJaNkEwcEhSTm55MTR3dUhPQmdV?oc=5","date":"2024-06-26","type":"trial","source":"BioPharma Dive","summary":"Novo nixes trial of blood pressure drug it bought in $1.3B deal - BioPharma Dive","headline":"Novo nixes trial of blood pressure drug it bought in $1.3B deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxNakZjYTR3ZFdlTWZ1R0w5X3ZYQkY1bTBsTkVNbGFEY28tYWhHSFFPU3gwMnFFZURTTWRtR1JzMlZQNk04bWdqck1tNFJ1MkFiQmtqMVZZdWhvT2RERjJJZ3dQZENnTjZxTTRUd0dzSGJ6NW1ZZElhX3BEWGppVUN3YWEzWDJUbDFnTm1BdVRhci10VmVleEI2NGNpQXN2UDA5SUI4UQ?oc=5","date":"2023-10-16","type":"deal","source":"Contract Pharma","summary":"Novo Nordisk to Acquire Ocedurenone from KBP Biosciences - Contract Pharma","headline":"Novo Nordisk to Acquire Ocedurenone from KBP Biosciences","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}